Article PDF
References
Bhalla, K.; Ibrado, A. M.; Toukina, E., et al. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563–568; 1993.
Chuang, L. T.; Lotzova, E.; Heath, J., et al. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res. 54:1286–1291; 1994.
Donaldson, K. L.; Goolsby, G. L.; Wahl, A. F. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer 57:847–855; 1994.
Fernandez, P.; Rotello, R.; Rangini, Z., et al. Expression of a specific marker of avian programmed cell death in both apoptosis and necrosis. Proc. Natl. Acad. Sci. USA 91:8652–8655; 1994.
Fujiwara, T. F.; Grimm, E. A.; Mukhopadhyay, T., et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res. 53:4129–4133; 1993.
Gangemi, R. M. R.; Tiso, M.; Marchetti, C., et al. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharmacol. 36:385–392; 1995.
Ho, Y.; Wang, Y.; Lin, J. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinog. 16:20–31; 1996.
Majumdar, S. K.; Andreassi, J.; Metzger, M., et al. Response of murine erythroleukemia cells to the anticancer drug, taxol. Cell Biol. Int. 480:565; 1994.
Majumdar, S. K.; Bachman, C. Evidence of apoptosis and necrosis in taxol treated murine erythroleukemia cells. Mol. Biol. Cell 7:194a; 1996.
Majumdar, S. K.; Welchel, B.; Bachman, C. Evidence of p53-dependent toxicity of taxol, an anti-cancer drug, on cultured murine erythroleukemia cells. In Vitro Cell. Dev. Biol. 32:62A-63A; 1996.
Milas, L.; Hunter, N. R.; Kurdoglu, B., et al. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35:297–303; 1995.
Milas, L.; Stephens, L. C.; Meyn, R. E. Relation of apoptosis to cancer therapy. In Vivo 8:665–674; 1994.
Oncogene Research Products. Wild-type p53-activated fragment ELISA product sheet. Cambridge, MA: 1996.
Rowinsky, E. K.; Donehower, R. C.; Tucker, R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 48:4093–4099; 1988.
Ryan, J. J.; Clarke, M. F. Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulf-oxide. Leuk. Res. 18:617–621; 1994.
Schwartz, L.; Smith, S.; Jones, M., et al. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA. 90:980–984; 1993.
Seiter, K.; Feldman, E. J.; Traganos, F., et al. Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel. Leukemia 9:1961–1983; 1995.
Speicher, L. A.; Barone, L.; Tew, K. D. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma lines. Cancer Res. 52:4433–4440; 1992.
Tishler, R. B.; Lamppu, D. M.; Park, S., et al. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 55:6021–6025; 1995.
Trauth, B. C.; Wittor, H.; Rubmann, E. Two non-radioactive immunoassays for the measurement of apoptotic cell death. Indianapolis, IN: Boehringer Mannheim Biochemicals; 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bachman, C.A., Bills, D.A. & Majumdar, S.K. Evidence of p53-induced apoptosis in cancer cells exposed to taxol. In Vitro Cell.Dev.Biol.-Animal 34, 434–435 (1998). https://doi.org/10.1007/s11626-998-0072-3
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11626-998-0072-3